Advances in monoclonal antibodies for radioimmunotherapy
Junfeng Yu
Abstract
Junfeng Yu
Abstract
This paper describes in detail the advances in monoclonal antibodies for radioimmunotherapy since 1990. It introduces the radionuclides, monoclonal antibodies including their dosimetry, toxicity and radiobiological characteristics in radioimmunotherapy. Finally it discusses the problems, potential solutions and future directions in developing monoclonal antibodies for radioimmunotherapy.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This paper describes in detail the advances in monoclonal antibodies for radioimmunotherapy since 1990. It introduces the radionuclides, monoclonal antibodies including their dosimetry, toxicity and radiobiological characteristics in radioimmunotherapy. Finally it discusses the problems, potential solutions and future directions in developing monoclonal antibodies for radioimmunotherapy.
Key concepts: Radioimmunotherapy, Monoclonal antibody, Dosimetry, Medicine, Antibody, Cancer research, Nuclear medicine, Immunology